Riskpilot← Back to searchSign inGet full accessFRIMED AS
ASActiveOrg 870993382Julsundvegen 93, 6412 MoldeOther human health activities n.e.c. · NACE 8699Est. 19942 employees
Revenue 2024
NOK 248K
-58% vs 2023
EBITDA margin
-64.7%
+54% vs 2023
Equity ratio
3.2%
Financial strength
Net profit 2024
NOK -252K
+25% vs 2023
| Revenue | NOK 248K | -58% |
| EBITDA | NOK -160K | +54% |
| Net profit | NOK -252K | +25% |
| Total assets | NOK 1,7M | -15% |
| Equity | NOK 54K | -82% |
| Employees | 2 | — |
Legal name
FRIMED AS
Org number
870993382
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
22. mai 1994
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Forebyggende og tjenesteytende virksomhet herunder kjøp,- salg og utleie av produkter innenfor helse- og sosialsektoren, og innen idrett og friluftsliv. Selskapet skal delta i forskning, undervisning, flerkulturelt arbeid samt alt som står i forbindelse med foranstående. Videre skal selskapet eie og forvalte verdipapirer og fast eiendom.
Address
Julsundvegen 93, 6412 Molde
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 2 188 | 2 999 | 2 917 | 3 862 | 2 597 | 688 | 277 | 288 | 372 | 653 | 2 758 | 3 248 | 2 982 | 2 111 | 2 069 | 583 | 248 |
| Staff expenses | −0 | −1 490 | −1 408 | −1 233 | −1 268 | −692 | −396 | −372 | −22 | −0 | −0 | −2 122 | −1 935 | −2 016 | −1 913 | −1 931 | −460 | −0 |
| EBITDA | 0 | −357 | 530 | 575 | 1 412 | 921 | −239 | −586 | 38 | 217 | −20 | 282 | 982 | 357 | −204 | −313 | −344 | −160 |
| Depreciation & amort. | −0 | −34 | −40 | −88 | −147 | −155 | −123 | −58 | −58 | −0 | −0 | −33 | −72 | −139 | −155 | −155 | −85 | −109 |
| EBIT | 0 | −390 | 490 | 487 | 1 265 | 766 | −361 | −643 | −20 | 217 | −20 | 248 | 910 | 218 | −359 | −468 | −430 | −269 |
| Net financials | 0 | −109 | −83 | −131 | −86 | −122 | −58 | −58 | −110 | −115 | −98 | 0 | 2 | −1 | −1 | −0 | −14 | −54 |
| Profit before tax | 0 | −499 | 407 | 357 | 1 179 | 644 | −419 | −701 | −130 | 102 | −118 | 248 | 912 | 217 | −360 | −468 | −444 | −323 |
| Tax | −0 | −89 | 118 | 100 | 334 | 180 | −124 | −190 | −13 | 36 | −17 | 66 | 201 | 48 | −79 | −103 | −106 | −71 |
| Net profit | 0 | −410 | 289 | 256 | 845 | 464 | −296 | −511 | −117 | 67 | −101 | 182 | 711 | 169 | −280 | −365 | −338 | −252 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 671 | 3 026 | 2 948 | 3 483 | 3 797 | 1 697 | 3 030 | 2 842 | 2 760 | 611 | 1 165 | 1 753 | 1 965 | 2 068 | 1 503 | 1 948 | 1 654 |
| Equity | — | −500 | −111 | 145 | 990 | 1 455 | 1 159 | 648 | 531 | 598 | 496 | 679 | 1 390 | 1 559 | 1 009 | 643 | 305 | 54 |
| Long-term debt | 0 | 765 | 2 733 | 2 097 | 1 986 | 1 981 | 159 | 2 096 | 1 968 | 1 838 | 40 | 3 | 5 | 53 | 693 | 493 | 1 436 | 1 351 |
| Short-term debt | 0 | 406 | 404 | 705 | 506 | 362 | 379 | 286 | 344 | 324 | 75 | 484 | 358 | 353 | 366 | 367 | 207 | 249 |
| Total debt | 0 | 1 171 | 3 137 | 2 803 | 2 492 | 2 343 | 538 | 2 382 | 2 311 | 2 162 | 115 | 487 | 363 | 406 | 1 059 | 860 | 1 643 | 1 600 |
EBITDA margin
-64.7%
This company
15.8%
Market median
-509% vs market
20072024
Equity ratio
3.2%
This company
38.2%
Market median
-92% vs market
20072024
Return on equity
-468.6%
This company
18.4%
Market median
-2647% vs market
20072024
Net profit margin
-101.7%
This company
8.1%
Market median
-1356% vs market
20072024
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20072024
Debt / equity
29.78×
This company
0.62×
Market median
-4703% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BO Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2010 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 8.0% | 8.0% | 2023 | |
| Individual | 8.0% | 8.0% | 2023 | |
| Individual | 8.0% | 8.0% | 2023 | |
| Individual | 8.0% | 8.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FRIMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørn Otterlei | Chief Executive Officer | 0 companies |
| Hanna Gjendem | Board of Directors | 0 companies |
| Hanna Otterlei | Board of Directors | 0 companies |